Nephron Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NEPHRON
NEPHRON has fifteen approved drugs.
Drugs and US Patents for Nephron
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nephron | IPRATROPIUM BROMIDE | ipratropium bromide | SOLUTION;INHALATION | 075562-001 | Sep 27, 2001 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Nephron | ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE | albuterol sulfate; ipratropium bromide | SOLUTION;INHALATION | 076749-001 | Dec 31, 2007 | AN | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Nephron | VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | SOLUTION;INTRAVENOUS | 213352-001 | Mar 17, 2020 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Nephron | METAPROTERENOL SULFATE | metaproterenol sulfate | SOLUTION;INHALATION | 071726-001 | Jul 14, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Nephron | NOREPINEPHRINE BITARTRATE | norepinephrine bitartrate | INJECTABLE;INJECTION | 216272-001 | Jun 11, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

